BERKELEY, Calif., March 19, 2019 /PRNewswire/ -- PRESS RELEASE -- "We are pleased to announce a licensee partnership with Green Analytics East to bring Steep Hill to New Jersey," said Jeffrey Monat, chairman of the Steep Hill Board of Directors. "Since 2008, Steep Hill has developed and now employs cutting edge cannabis testing practices, providing analysis to ensure safe medicine and products. With Green Analytics East as our trusted partner, New Jersey patients and consumers can be confident that all Steep Hill-tested products will fully comply with public safety and regulatory standards."
Shannon Hoffman, director of operations of Steep Hill New Jersey said, "We are excited to bring our focus of service, accuracy and scientific knowledge and expertise to the New Jersey market. We look forward to serving the licensed producers, the patient community and hopefully soon, the adult use consumer."
New Jersey is poised to legalize adult use this year and is expected to be a robust market. Testing regulations for independent testing laboratories have not been published yet.
Steep Hill New Jersey is currently working to obtain the local permits and is projected to be open for regulatory testing in the third quarter of 2019.
